Efficacy and safety of topical minocycline foam (FMX101 4%) in treatment of Chinese subjects with moderate‐to‐severe facial acne vulgaris: A phase 3, multi‐centre, randomized, double‐blind, vehicle‐controlled study

Yan Le(Fudan University), Leihong Xiang(Fudan University), Bin Yang(Southern Medical University), Jiu‐Hong Li(First Hospital of China Medical University), Yangfeng Ding(Shanghai Stomatological Hospital), Songmei Geng(Second Affiliated Hospital of Xi'an Jiaotong University), Linda Wang(Montreal Heart Institute), Jianyun Lu(Washington University in St. Louis), Xian Jiang(Nanfang Hospital), Chunyun Huang(Fudan University), Wei Zhu(Fudan University), Xiao‐Yong Man(Second Affiliated Hospital of Zhejiang University), Yanling Li(Hebei Medical University), Linfeng Li(Beijing Tongren Hospital), Shanshan Li(Jilin University), Jin Chen(Beijing Institute of Neurosurgery), Chunlei Zhang(Peking University), Yi Zhao(Beijing Tsinghua Chang Gung Hospital), Tong Lin(Chinese Academy of Medical Sciences Dermatology Hospital), Qing Guo(Sun Yat-sen University), Xiuping Han(China Medical University), Hao Cheng(Sir Run Run Shaw Hospital), Yong Cui(Anhui Medical University), Litao Zhang(Tianjin University of Traditional Chinese Medicine), Huiping Wang(Chinese National Human Genome Center), Zhiqiang Song(Army Medical University), Wenlin Yang(Second Affiliated Hospital of Guangzhou Medical University), Yuefang Zhu(Regend Therapeutics (China)), Mingye Bi(Fujian Normal University), Qing Sun(Qilu Hospital of Shandong University), Haiying Wang(Tianjin Medical University General Hospital), Aie Xu(Third People's Hospital of Hangzhou)
Journal of the European Academy of Dermatology and Venereology
July 1, 2024
Cited by 5


Related Papers